Engineered allogeneic T cells decoupling T-cell-receptor and CD3 signalling enhance the antitumour activity of bispecific antibodies.
Kapetanovic E, Weber CR, Bruand M, Pöschl D, Kucharczyk J, Hirth E, Dietsche C, Khan R, Wagner B, Belli O, Vazquez-Lombardi R, Castellanos-Rueda R, Di Roberto RB, Kalinka K, Raess L, Ly K, Rai S, Dittrich PS, Platt RJ, Oricchio E, Reddy ST.
Kapetanovic E, et al. Among authors: di roberto rb.
Nat Biomed Eng. 2024 Dec;8(12):1665-1681. doi: 10.1038/s41551-024-01255-x. Epub 2024 Sep 25.
Nat Biomed Eng. 2024.
PMID: 39322719
Free PMC article.